BPC-157 for tendonitis: what the evidence actually shows

What did @moremayamoore actually say?

The video clips what appears to be a podcast conversation, likely connected to the Joe Rogan hashtag, where speakers describe BPC-157 as something that "absolutely works" and "definitely does accelerate healing." The most striking claim: a full rotator cuff tear allegedly resolved completely after using BPC-157, with one speaker saying "I've never seen a rotator cuff tear, full length rotator cuff tear go away" without surgery. A personal anecdote about elbow tendonitis disappearing in two weeks after using BPC-157 is also presented as evidence the peptide works. The framing throughout is certainty, not possibility.

There's also some loose terminology worth flagging. The speakers refer to both "BPC-157" and "GP157" interchangeably, which is either a nickname or a slip, and describe peptides as things "the gut is happy" body secretes to heal faster. That's a rough simplification that misrepresents how BPC-157 actually works pharmacologically.

Does the science back this up?

Preclinical evidence for BPC-157 is genuinely interesting. But calling it a certainty that it heals human tendons is a stretch the current data does not support.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. In rodent models, it has shown consistent pro-healing effects on tendons, muscles, and ligaments. Sikiric et al. (2018, Current Pharmaceutical Design) documented accelerated tendon-to-bone healing and upregulation of growth hormone receptors in rat models. Chang et al. (2011, Journal of Applied Physiology) showed improved tendon fibroblast survival and organization after BPC-157 application in animal studies.

The problem is that virtually all of this research is animal-based. There are no published, peer-reviewed randomized controlled trials in humans evaluating BPC-157 for tendinopathy or rotator cuff repair. The FDA has not approved it for any indication. The leap from "works in rats" to "healed my full rotator cuff tear" is not a small one. It is the entire scientific credibility gap.

What did they get wrong (or right)?

They got the basic biology roughly right. Peptides are small strings of amino acids, and BPC-157 does appear to influence healing pathways, at least in animals. Credit where it is due.

But several claims cross from interesting to irresponsible. Saying BPC-157 "definitely does accelerate healing" in humans is stated as fact when no human clinical trial evidence exists to confirm this. Presenting a full rotator cuff tear resolving without surgery as a documented outcome of BPC-157 use is not supported by any published evidence, and the speaker admits they've "never seen this before," which should have been a reason for caution, not celebration.

The gut secretion explanation is also muddled. BPC-157 is not naturally secreted by a "happy gut" in the way described. It is a synthetic analog of a gastric peptide, not something your body produces in meaningful therapeutic quantities in response to gut health. That framing misleads people about what they're actually taking.

Anecdotal recovery stories, even compelling ones, are not evidence. Tendonitis often resolves on its own. Without a control condition, there is no way to know what caused the two-week recovery.

What should you actually know?

BPC-157 is not FDA-approved, not legal to sell as a dietary supplement, and sits in a regulatory gray zone as a research compound. In 2022, the FDA clarified that BPC-157 cannot be compounded by pharmacies for clinical use, citing insufficient evidence of safety and efficacy in humans.

That does not mean it has zero potential. Researchers are still studying it. Some sports medicine and regenerative medicine practitioners use it off-label, accepting the risk-benefit tradeoff with patients who understand the evidence gap. But that is a clinical conversation, not a TikTok recommendation.

If you have tendonitis or a rotator cuff injury, physical therapy with eccentric loading protocols has robust human evidence behind it (Kongsgaard et al., 2009, Scandinavian Journal of Medicine and Science in Sports). Platelet-rich plasma injections remain controversial but have more human trial data than BPC-157. These are conversations to have with a musculoskeletal specialist, not decisions to make based on a podcast clip.

Anyone considering peptide therapy should consult a licensed clinician, understand that these compounds are not regulated like medications, and be skeptical of anyone who calls results "absolutely" guaranteed.